CBS - The 17th Left Main & Coronary Bifurcation Summit, CBS2025

CBS 2019

CBSMD教育中心

HOME
CBS 2019
At CBS

General Information

Left Main & Coronary Bifurcation Summit (CBS) was founded in 2006 as a think tank dedicated to the treatment of left main and coronary bifurcation lesions. CBS aims to improve cardiological care by refreshing fundamental researches, clinical trials, yearly published guidelines, emerged ideas and case-based discussion.

Association and Affiliations
- Organized by
  
  Nanjing Heart Center
  
  Asian Bifurcation Club (ABC)
  
  Nanjing First Hospital, Nanjing Medical University
- Co-organized by
  
  Chinese Society of Cardiology (CSC)
  
  Capacity Building and Continuing Education Center,National Health and Family Planning Commission (CBCEC)
  
  American Society for Cardiovascular Angiography and Interventions (SCAI)
  
  Asian Heart Society (AHS)
Contact Us
- Registration Administration of Domestic Representatives
  
  Hongjuan Peng : +86-13913895477
  
  Haimei Xu +86-13914736846
  
  cbsnj@cbsmd.cn
- Registration Administration of Overseas Representatives
  
  Ling Lin : +86 (25) 52271398
  
  +86-13951884596
  
  cbs@cbsmd.cn
- Management of Challenging Cases
  
  Yingying Zhao :+86-13815408517
  
  sub@cbsmd.cn
Address

CBS2019 Congress Secretariat, Nanjing First Hospital, Building No.9 68# Changle Road, Nanjing, China

210006
FACULTY
FACULTY

General Chairman
Congress Chairman
Course Directors International Faculty Domestic Faculty Hong Kong and Taiwan Faculty Members of Academic Committee
Education Center

Education Center

• Online Education (For more customized user interface with self-defined collection of research papers and education resources.)

• CBS Education Resource

• CBSMD Scientific Library
SCIENTIFIC LIBRARY

SCIENTIFIC LIBRARY

Research Paper

> Acute Coronary Syndrom

> ASCVD Prevention

> Bifurcation Stenting

> Cardio-Oncology

> Congestive Heart Failure

> DAPT Duration

> Drug Coated Balloon

> Fractional Flow Reserve

> IVUS Guidance

> Optical Coherence Tomography

> Pulmonary Hypertension

> Rotational Atherectomy

> Shear Stress

> Stenting Left Main

> Transcatheter Aortic Valve Replacement

> Percutaneous LAA Occlusion

> Mitral/Tricuspid Valvular Disease

> Other Relevant Articles

Recommended Paper

Management of Acute Myocardial Infarction During the COVID-19 Pandemic

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

CSC Expert Consensus on Principles of Clinical Management of Patients with Severe Emergent Cardiovascular Diseases during the COVID-19 Epidemic

ACC Clinical Bulletin Focuses on Cardiac Implications of Coronavirus (COVID-19)

HOME | SCIENTIFIC LIBRARY | 血管内超声指导

血管内超声指导

Impact of intravascular ultrasound-guided percutaneous coronary intervention on long-term clinical outcomes in a real world population First-in-man evaluation of intravascular optical frequency domain imaging (OFDI) of Terumo: a comparison with intravascular ultrasound and quantitative coronary angiography A Randomized Study of Distal Filter Protection Versus Conventional Treatment During Percutaneous Coronary Intervention in Patients With Attenuated Plaque Identified by Intravascular Ultrasound Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study Assessment of coronary atherosclerosis by IVUS and IVUS-based imaging modalities: progression and regression studies, tissue composition and beyond Comparison of intravascular ultrasound guided versus angiography guided drug eluting stent implantation: a systematic review and meta-analysis Temporal Trends in Inpatient Use of Intravascular Imaging Among Patients Undergoing Percutaneous Coronary Intervention in the United States Intravascular ultrasound predictors for edge restenosis after newer generation drug-eluting stent implantation

Sort by hits |<<... 2 3 4 5 6 7 8 ...>>|

JOURNAL：CBS2017 Article Link

PADN绽放在ESC2017

CBS2017

ESC2017盛大开幕！

欧洲心脏病学会（European Society of Cardiology）2017届年会于当地时间8月26日上午8点半（北京时间26日下午14点半）盛大开幕，全球3万多医生及医疗工作者汇聚西班牙巴塞罗那参加此次盛会。ESC由来自全球56个国家级心脏学会医疗专家志愿者组成，现有成员95000名，27个专科分会，43个附属心脏学会。

本次ESC大会发布了双抗治疗、急性ST段抬高型心肌梗死（ST segment elevation myocardial infarction, STEMI）、外周动脉疾病（Peripheral Arterial Diseases）及心脏瓣膜疾病（Valvular Heart Disease）四个方面的最新循证医学依据的诊治指南。点击此处详细阅读相关最新指南内容。

27日上午，陈绍良教授在ESC大会现场做了围绕肺动脉高压的介入治疗、机制及疗效的“肺动脉高压介入治疗”专题学术报告。陈绍良教授创新性提出通过肺动脉去神经术治疗肺动脉高压。迄今，该技术已在中国、美国、俄罗斯等国家广泛推广应用，为肺动脉高压这个世界性难题提供了新的治疗方向及策略，给患者带来希望。

肺动脉高压（PAH）一直属于世界性难题，一部分患者无法从单药治疗甚至多联靶向药物治疗中获益，治愈率低、死亡率高、卫生费用高。近年来，随着对心功能不全继发PH的认识深入，寻找更加积极有效的非药物治疗迫在眉睫。陈绍良教授团队创新的经皮肺动脉去神经术（PADN）改变了这一局面。在本次ESC论坛上，陈绍良教授分享了团队从动物实验入手，验证PADN术的有效性和安全性，直至开展临床研究的发展历程。

8月28日，巴黎时间9点-10点巴塞罗那厅-ESC2017第26会场，陈绍良教授将就冠脉介入治疗做专题学术报告，让我们共同拭目以待。

此行，陈绍良教授将在ESC大会上着重宣传即将于11月30日在中国·南京召开的CBS2017大会。作为左主干、冠脉分叉病变领域的前沿大会，CBS一直秉持开放交流、造福世界的理念，为全球患者获益而持续努力。